Health Network Laboratories Acquires MDx Testing Firm Connective Tissue Gene Tests

Jan 14, 2019

NEW YORK (360Dx) – Health Network Laboratories announced today the acquisition of Connective Tissue Gene Tests, a molecular diagnostic laboratory specializing in inherited genetic disorders.

CTGT, founded in 2004, uses proprietary analytic methods and a mutation database to provide more than 3,000 unique tests covering 1,000 genes. The company's systems have enabled it to rapidly develop and deploy new tests, according to HNL.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Breaking News

Featured White Papers

Type 1 Interferon Gene Expression Analysis: Precision Medicine in Lupus

Jul

23

Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.

Jul

30

Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Menu